Malaria standby emergency treatment (SBET) for travellers visiting malaria endemic areas: a systematic review and meta-analysis
| Autor: | Blaise Genton, Rainer Tan, Jolanda Elmers |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Travel
Rapid diagnostic test Antimalarials/adverse effects Antimalarials/therapeutic use Emergency Treatment Humans Malaria/prevention & control Medication Adherence/statistics & numerical data Malaria SBET mRDT meta-analysis standby emergency treatment systematic review traveller business.industry 030231 tropical medicine MEDLINE General Medicine medicine.disease Confidence interval Medication Adherence Antimalarials 03 medical and health sciences 0302 clinical medicine Health facility Meta-analysis Environmental health medicine 030212 general & internal medicine Prospective cohort study business Adverse effect |
| Zdroj: | Journal of travel medicine, vol. 26, no. 4 |
| ISSN: | 1708-8305 1195-1982 |
| DOI: | 10.1093/jtm/taz027 |
| Popis: | Background Malaria prevention methods for travellers to low or moderate malaria risk areas vary and remain controversial. Standby emergency treatment (SBET) for malaria is one possible strategy increasingly recommended since 1988 with little evidence on its effectiveness or how it is truly being used. Methods A systematic review and meta-analysis were performed based on a structured search in Embase, Medline, PubMed, Cochrane and Web of Science on 7 September 2018. The primary outcome was the overall prevalence of SBET use in travellers, and secondary outcomes were the proportion carrying SBET, the response to fever [use of SBET, health facility attendance and use of malaria rapid diagnostic test (mRDT)], adverse events to SBET and the proportion using SBET incorrectly (incorrect dosage/duration). The pooled SBET use prevalence was analysed using a random effects model. A descriptive summary was done to present secondary outcomes. The study protocol was registered with PROSPERO CRD42018103703. Results A total of 11 studies were eligible for inclusion among the 1027 titles identified by our search. The studies included 7/11 prospective cohort studies that recruited pre-travel clinic attendees in Europe and 4/11 cross-sectional studies, of which 3 recruited travellers at airports before their return home from Southeast Asia and Africa and 1 from an employee registry including long-term travellers. The overall pooled prevalence of SBET use among the 26 403 travellers was 2.5% (95% confidence interval, 1.1-4.3%; range, 0.4-10.8%). There was significant variation in the proportion of travellers carrying SBET medication (40-100%), the proportion of travellers with appropriate response to fever (23-100%), adverse events (0-33%) and incorrect dosage/duration of SBET (0-100%). Conclusion Adherence to the proposed recommendations for SBET use, notably the response to fever, was poor. If the use of SBET is to be pursued, modifications to the current SBET strategy should be considered, such as better selection of travellers at higher risk for malaria and the potential addition of mRDTs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|